MiMedx Group Executive and Leadership Team

November, 2026

Leadership Overview

MiMedx Group has 4 executives leading key functions including corporate strategy, financial operations, clinical development, and administrative governance.

Focused on advancing regenerative medicine through proprietary placental tissue technologies, MiMedx Group delivers innovative allografts to improve patient outcomes across wound care, surgical, and orthopedic sectors globally.

Leadership Roles at MiMedx Group

  • Chief Executive Officer - Joseph Capper
  • Chief Financial Officer - Doug Rice
  • Head Chief Marketing Officer, Clinical Development - David Mason
  • General Counsel & Chief Administrative Officer - William Hulse
  • Joseph Capper - Chief Executive Officer

    Joseph Capper, the Chief Executive Officer at MiMedx Group, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the development of regenerative biologics, Capper ensures the company maintains a competitive edge in the biopharmaceutical market. This leadership role involves aligning internal research initiatives with external market demands for advanced placental tissue allografts. By fostering collaboration across departments, Capper drives operational excellence and sustainable growth. The Chief Executive Officer manages high-level relationships with stakeholders and the Board to secure the financial health of the enterprise. Through the implementation of the proprietary PURION Process, Capper expands the reach of AmnioFix and EpiFix technologies into diverse healthcare sectors. Joseph Capper maintains a focus on scaling operations to meet the increasing demand for musculoskeletal repair solutions, ensuring the company remains a leader in the regenerative medicine industry while delivering consistent value to shareholders and patients alike.
    Joseph Capper

    Doug Rice - Chief Financial Officer

    Doug Rice, the Chief Financial Officer at MiMedx Group, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning, reporting, and risk management, Rice ensures the company maintains the necessary liquidity to support ongoing research and development of placental tissue allografts. This leadership role involves optimizing the cost structure of the proprietary PURION Process to maximize margins across the product portfolio. By analyzing market trends and operational performance, Rice provides the data-driven insights required for strategic decision-making at the executive level. The Chief Financial Officer coordinates with the sales force and distribution partners to monitor revenue streams across North American and international markets. Doug Rice secures the financial stability required to advance the CollaFix and AmnioCord platforms, ensuring that capital investments align with the long-term growth objectives of the business. Through rigorous financial oversight, Rice supports the expansion of the company into new clinical applications.

    David Mason - Head Chief Marketing Officer, Clinical Development

    David Mason, the Head Chief Marketing Officer, Clinical Development at MiMedx Group, architects the commercialization strategy and clinical evidence programs for the company. Overseeing the translation of scientific data into market-ready messaging, Mason ensures that the benefits of AmnioFix and EpiFix are clearly communicated to healthcare providers. This leadership role involves managing the clinical development pipeline to validate the efficacy of allografts in wound care, burns, and sports medicine. By bridging the gap between clinical research and commercial adoption, Mason drives the market penetration of advanced tissue technologies. The Head Chief Marketing Officer, Clinical Development coordinates with the direct sales force to equip representatives with the technical knowledge required for complex surgical environments. David Mason monitors the competitive landscape to refine product positioning and capture additional market share. Through the integration of clinical insights into marketing campaigns, Mason accelerates the adoption of regenerative solutions, ultimately enhancing the standard of care for patients requiring musculoskeletal repair.

    William Hulse - General Counsel & Chief Administrative Officer

    William Hulse, the General Counsel & Chief Administrative Officer at MiMedx Group, governs the legal framework and administrative infrastructure of the organization. Overseeing regulatory compliance and intellectual property protection, Hulse ensures the proprietary PURION Process and associated technologies remain secure within the competitive biopharmaceutical landscape. This leadership role involves managing corporate governance, risk mitigation, and legal affairs to support the operational integrity of the company. By streamlining administrative processes, Hulse improves organizational efficiency and ensures alignment with industry standards across all departments. The General Counsel & Chief Administrative Officer collaborates with the executive team to navigate complex legal challenges associated with international distribution and product licensing. William Hulse provides the foundational support necessary for the company to scale its operations in the United States and abroad. Through the management of legal and administrative functions, Hulse protects the assets of the business while facilitating the seamless execution of corporate initiatives and strategic partnerships.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding MiMedx Group Top Executives and Leadership Team

    Who leads MiMedx Group?
    MiMedx Group is led by Joseph Capper (Chief Executive Officer), along with executives such as Doug Rice (Chief Financial Officer) and David Mason (Head Chief Marketing Officer, Clinical Development).
    Who is part of MiMedx Group’s executive team?
    The executive team of MiMedx Group includes leaders such as Joseph Capper (Chief Executive Officer), Doug Rice (Chief Financial Officer), David Mason (Head Chief Marketing Officer, Clinical Development) and other senior executives.
    How many executives does MiMedx Group have?
    MiMedx Group has 4 executives leading key business areas.
    What roles are included in MiMedx Group’s leadership team?
    The leadership team of MiMedx Group includes roles such as Chief Executive Officer, Chief Financial Officer, Head Chief Marketing Officer, Clinical Development, General Counsel & Chief Administrative Officer.